May 29, 2024
by Andrii Buvailo, PhD
Biopharma insight
For many years, the focus of therapeutic developments and scientific research was directed at the genome and proteins. Yet, there …
May 21, 2024
by Roman Kasianov
Biopharma insight
Insilico Medicine, a clinical-stage AI-driven drug discovery company, in collaboration with NVIDIA, has introduced nach0, a novel large language model …
May 9, 2024
by Andrii Buvailo, PhD
Biopharma insight
In the dynamic world of drug discovery, companies must continually innovate beyond their existing drug portfolios and modalities. Relying solely …
May 3, 2024
by Andrii Buvailo
Biopharma insight
The advent of artificial intelligence (AI) in healthcare has catalyzed an epoch of change, reshaping diagnostic procedures, therapeutic strategies, and …
May 3, 2024
by Travis McCready
Biopharma insight
Artificial intelligence (AI) is one of the most disruptive technologies the Life Sciences sector has ever seen. It’s having a …
April 29, 2024
by Louise von Stechow
Biopharma insight
Drug development for rare (also referred to as orphan) diseases is notoriously challenging. Legislative initiatives, such as the 1983 US …
April 29, 2024
by Dr. Alexander Jarasch
Biopharma insight
Data in Life Sciences expert Dr Alexander Jarasch on a new wave of advanced data handling techniques that point the …
April 21, 2024
Biopharma insight
We have recently launched a report, “It’s Been a Decade of AI in the Drug Discovery Race. What’s Next?” where …
April 17, 2024
by Viraj Mehta
Biopharma insight
Report highlights: We are currently at an exciting juncture where several big pharmaceutical companies have started adopting such models and …
April 9, 2024
by Bohdana Sokolova
Biopharma insight
The world of clinical trials is undergoing an evolution as the rise of decentralized clinical trials (DCTs) brings about a change …
April 8, 2024
by Andrii Buvailo
Biopharma insight
Sponsored by Lantern Pharma
Clinical trials are the lifeline of modern medicine, bridging the gap between lab-borne scientific discoveries and the availability of life-saving …
April 7, 2024
by Andrii Buvailo, PhD
Biopharma insight
In a detailed interview, Dr. Brian Jamieson, founder and CTO of Diagnostic Biochips (DBC), delves into the evolving landscape of …